НЕВРОЛОГИЧЕСКИЕ ОСЛОЖНЕНИЯ ХРОНИЧЕСКОГО ЛИМФОЛЕЙКОЗА У ВЗРОСЛЫХ


Цитировать

Полный текст

Аннотация

Приведен обзор литературы по неврологическим осложнениям хронического лимфолейкоза у взрослых. Дано их подробное клиническое описание, рассмотрены основные вопросы их диагностики и лечения.

Об авторах

Динара Равильевна Терегулова

Городская клиническая больница №5

Email: dinamail@mail.ru
450005, г.Уфа, ул. Пархоменко, д. 93

Булат Ахатович Бакиров

Клиника Башкирского государственного медицинского университета

Email: bakirovb@gmail.com
450059, г. Уфа, ул. Шафиева, д. 2

Денис Энверович Байков

Клиника Башкирского государственного медицинского университета

450059, г. Уфа, ул. Шафиева, д. 2

Лейла Ринатовна Ахмадеева

Башкирский государственный медицинский университет

Email: la@ufaneuro.org
кафедра неврологии с курсами нейрохирургии и медицинской генетики г. Уфа, ул. Ленина, д. 3

Список литературы

  1. Доронин В.А., Худолеева О.А., Пашин Л.Е. и др. Поражение центральной нервной системы при В-клеточном хроническом лимфолейкозе (клинический случай и обзор литературы) // Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2008. Т.1, № 2. С. 164-167.
  2. Избранные лекции по внутренним болезням. Болезни органов пищеварения, почек, крови и соединительной ткани [под ред. Мирсаевой Г.Х., Мавзютовой Г.А.]. Уфа: ГУП РБ Уфимский полиграфический комбинат, 2013. С. 254-260.
  3. Королёва Н.В., А.Б. Карпов, P.M. Тахауов и др. Оценка распространённости гемобластозов среди детского населения г. Северска // Бюлл. сибирской медицины. 2007. №2. С. 103-109.
  4. Чигринова Е. В., Бялик Т. Е., Андреева Л. Ю. и др. Хронический В-клеточный лимфолейкоз у лиц моложе 30 лет: агрессивное клиническое течение и рефрактерность к химиотерапии // Гематология и трансфузиология. 2004. №3. С. 11-15.
  5. Abedalthagafi M., Rushing E.J., Garvin D. et al. Asymptomatic diffuse “encephalitic”cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literature // Int. J. Clin. Exp. Pathol. 2009. Vol. 3. P. 106-9.
  6. Altaf A.R., Hansen P.B. Life-threatening hyponatremia provoked by alternative treatment. An occurrence in a patient with chronic lymphocytic leukemia with no indication for treatment // Ugeskr Laeger. 2007. Vol. 169. P. 4367-4368.
  7. Amend K.L., Turnbull B., Foskett N. et al. Incidence of progressive multifocal leukoencephalopathy in patients without HIV // Neurology. 2010. Vol. 75. P. 1326-1332.
  8. Anaissie E.J., Kontoyiannis D.P., O’Brien S. et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine // Ann. Intern. Med. 1998. Vol.129. P. 559-566.
  9. Bacchu S., Fegan C., Neal J. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine // Br. J. Haematol. 2007. Vol. 139. P. 349.
  10. Barcos M., Lane W, Gomez GA, et al. An autopsy study of 1206 acute and chronic leukemias (1958 to 1982) // Cancer.1987. Vol. 60. P. 827-37.
  11. Blaes F., Tschernatsch M. Paraneoplastic neurological disorders // Expert Rev. Neurother. 2010. Vol. 10. P. 1559-1568.
  12. Bojsen-Moller M., Nielsen J.L. CNS involvement in leukaemia. An autopsy study of 100 consecutive patients // Acta. Pathol. Microbiol. Immunol. Scand. 1983. Vol. 91. P. 209-216.
  13. Bosch E.P., Habermann T.M., Tefferi A. Peripheral neuropathy associated with lymphoma, leukemia and myeloproliferative disorders. In: Dyck P.J., Thomas P.K., eds. Peripheral Neuropathy. 4th edition. Philadelphia,Elsevier Saunders.2005. P. 2489-2503.
  14. Bower J.H., Hammack J.E. Shannon K. et al. The neurologic complications of B-cell chronic lymphocytic leukemia // Neurology. 1997. Vol. 48. P. 407-412.
  15. Bruce D.R., Rane N.S., Schuh A. Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia // Br. J. Haematol. 2014. Vol. 167(4). P. 570-571.
  16. Chamberlain M.C. Leukemia and the nervous system // Current Oncology Reports. 2005. Vol. 7, I.1. P. 66-73.
  17. Cheson B.D., Vena D.A., Foss F.M.,et al. Neurotoxicity of purine analogs: a review // J. Clin. Oncol. 1994. Vol. 12. P. 2216-2228.
  18. Counsel P., Khangure M. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings // Clin. Radiol. 2007. Vol.62. P. 172-176.
  19. Cramer S.C, Glaspy J.A, Efird J.T. et al. Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study // Neurology. 1996. Vol. 46. P. 19-25.
  20. Creange A., Theodorou I., Sabourin J.C. et al. Inflammatory neuromuscular disorders associated with chronic lymphoid leukemia: evidence for clonal B cells within muscle and nerve // J. Neurol. Sci. 1996. Vol. 137. P. 35-41.
  21. De Lima M., O’Brien S., Lerner S. et al. Chronic lymphocytic leukemia in the young patient // Semin. Oncol. 1998. Vol. 25(1). P. 107-116.
  22. De Vito N., Mui K., Jassam Y. et al. Small lymphocytic lymphoma presenting as a paraneoplastic syndrome with acute central nervous system demyelination // Clinical Lymphoma, Myeloma & Leukemia. 2014. Vol. 14(4). P. 131-135.
  23. Di Pauli F., Berger T., Walder A. et al. Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature // J. Clin. Virol. 2014. Vol. 60(4). P. 427-427.
  24. D’Souza A, Wilson J, Mukherjee S, et al. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature // Clin Lymphoma Myeloma Leuk. 2010. Vol. 10. P. 1-9.
  25. D’Souza S.L., Santiago F., D’Moura Ribeiro-Carvalho M. Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature // BMC Research Notes. 2014. Vol. 7. P. 645.
  26. Elliott M.A., Letendre L., Chin-Yang L. et al. Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine // Br. J. Haematol. 1999. Vol. 104. P. 689-694.
  27. Eloraby A.M. L-asparaginase therapy with concomitant cranial venous thrombosis: can MRI help avoid stroke // J. Egypt. Natl. Cancer Inst. 2009. Vol. 21. P. 43-50.
  28. García-Suárez J., de Miguel D., Krsnik I. et al. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies // Am. J. Hematol. 2005. Vol.80. P. 271-281.
  29. Getaz E.P., Miller G.J. Spinal cord involvement in chronic lymphocytic leukemia // Cancer.1979. Vol. 43. P.1858-1861.
  30. Glantz M.J., Cole B.F, Glantz L.K. et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results // Cancer. 1998. Vol. 82. P. 733-739.
  31. Gonzalez H., Bolgert F., Camporo P. et al. Progressive multifocal leukoencephalitis (PML) in three patients treated with standard dose fludarabine (FAMP) // Hemato. Cell Ther.1999. Vol. 41. P. 183-186.
  32. Graus F., Delattre J.Y., Antoine J.C. et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes // J. Neurol. Neurosurg. Psychiatry. 2004. Vol. 75. P.1135-1140.
  33. Hafner J., Kumar K., Mulligan S. et al. Multifocal central nervous system demyelination and Lhermitte’s phenomenon secondary to combination chemotherapy for chronic lymphocytic leukaemia // J. Neurol. Sci. 2014. Vol. 338 (1-2). P. 218-219.
  34. Hagberg H., Lannemyr O., Acosta S. et al. Successful treatment of syndrome of inappropriate antidiuretic secretion (SIADH) in 2 patients with CNS involvement of chronic lymphocytic leukaemia // Eur. J. Haematol. 1997. Vol. 58. P. 207-208.
  35. Haider I., Cahill M. Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy // Hematology. 2004. Vol. 9. P.409-211.
  36. Hamblin T.J. Autoimmune complications of chronic lymphocytic leukemia // Semin. Oncol. 2006. Vol. 33. P. 230-239.
  37. Hasselbach H.C., Fickenscher H., Nölle B.et al. Atypical ocular toxoplasmosis with concomitant ocular reactivation of varicella-zoster virus and cytomegalovirus in an immunocompromised host // Klin. Monbl. Augenheilkd. 2008. Vol. 225. P. 236-239.
  38. Heidys G., De la Fuente A., Ona R. Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia // Exp. Hematol. Oncol. 2015. Vol. 4. P. 8.
  39. Holtzer-Goor K.M., Schaafsma M.R., Joosten R. Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study // Qual Life Res. 24.07. 2015. URL: http://link.springer.com/article/10.1007%2Fs11136-015-1039-y.
  40. Holzapfel C., Kellinghaus C., Lüttmann R. et al. Progressive multifocal leukoencephalopathy (PML) in chronic lymphatic leukemia (CLL). Review of the literature and case report // Nervenarzt. 2002. Vol. 73. P. 543-547.
  41. Honnorat J. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes // Acta. Neurol. Scand. Suppl. 2006. Vol. 183. P. 64-68.
  42. Hughes B.A., Kimmel D.W., Aksamit A.J. Herpes zoster-associated meningoencephalitis in patients with systemic cancer // Mayo. Clin. Proc. 1993. Vol. 68. P. 652-655.
  43. Kang J.H., Sheu J.J., Lin H.C. Increased risk of Guillain-Barré syndrome following recent herpes zoster: a population-based study across Taiwan // Clin. Infect. Dis. 2010. Vol. 51. P. 525-530.
  44. Kelly K., Lynch K., Farrell M. et al. Intracranial small lymphocytic lymphoma // Br. J. Haematol. 2008. Vol. 141. P.411.
  45. Lange C.P., Brouwer R.E., Brooimans R. et al. Leptomeningeal disease in chronic lymphocytic leukemia // Clin. Neurol. Neurosurg. 2007. Vol. 109. P. 896-901.
  46. Laugen R.H., Carey R.M., Wills M.R.et al. Hypercalcemia associated with chronic lymphocytic leukemia // Arch. Intern. Med. 1979. Vol. 139. P. 1307-1309.
  47. Lee S.H., Hur J., Kim Y.J. et al. Additional value of dual-energy CT to differentiate between benign and malignant mediastinal tumors: an initial experience // Eur. J. Radiol. 2013. Vol. 82. P. 2043-2049.
  48. Lopes Da Silva R. Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia // Clinical Lymphoma, Myeloma & Leukemia. 2012. Vol. 12, № 3. P. 164-79.
  49. Lustman F., Flament-Durant J., Colle H. et al. Paraplegia due to epidural infiltration in a case of chronic lymphocytic leukemia // J. Neurooncol. 1988. Vol.6. P. 59-60.
  50. Majumdar G. Chronic lymphocytic leukaemia with cerebral infiltration // Leuk. Lymphoma.1998. Vol. 28. P. 603-605.
  51. Marmont A.M. Leukemic meningitis in B-cell chronic lymphocytic leukemia: resolution following intrathecal methotrexate // Blood. 2000. Vol. 96. P. 776-777.
  52. Messori A., Fadda V., Maratea D. et al. First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis // Ann. Hematol. 2015. Vol. 94(6). P. 1003-1009.
  53. Michalevicz R., Burstein A., Razon N. et al. Spinal epidural compression in chronic lymphocytic leukemia // Cancer. 1989. Vol. 64. P. 1961-1964.
  54. Morrison C., Shah S., Flinn I.W. Leptomeningeal involvement in chronic lymphocytic leukemia // Cancer Pract. 1998. Vol. 6, № 4. P. 223-228.
  55. Nimubona S., Bernard M., Morice P. et al. Complications of malignancy: case 3. Chronic lymphocytic leukemia presenting with panhypopituitarism // J. Clin. Oncol. 2004. Vol. 22. P. 274-276.
  56. Nowakowski G.S., Call T.G., Morice W.G. et al. Clinical significance of monoclonal B-cells in cerebrospinal fluid // Cytometry B Clin. Cytom. 2005. Vol. 63. P. 23-27.
  57. Reisfeld-Zadok S., Elis A., Szyper-Kravitz M. et al. Cryptococcal meningitis in chronic lymphocytic leukemia patients // Isr. Med. Assoc J. 2009. Vol. 11. P. 437-439.
  58. Reske-Nielsen E., Petersen J.H., Sogaard H. et al. Leukaemia of the central nervous system // Lancet. 1974. Vol. 1. P. 211-212.
  59. Rey J., Attarian S., Disdier P. et al. Myasthenia gravis and chronic lymphocytic leukemia: a lucky association // Rev. Med. Interne. 2001. Vol. 22. P. 1129-1130.
  60. Rye A.D., Stitson R.N., Dyer M.J. Pituitary infiltration in B-cell chronic lymphocytic Leukaemia // Br. J. Haematol. 2001. Vol. 115. P. 718.
  61. Salloum E., Khan K.K., Cooper D.L. Chlorambucil-induced seizures // Cancer. 1997. Vol. 79. P. 1009-1013.
  62. Sengupta S., Benkers T., Blitstein M. et al. Posterior Reversible Encephalopathy Syndrome (PRES) Complicating Newly-Diagnosed Diffuse Large B-Cell Lymphoma // Clin. Lymphoma Myeloma Leuk. 2014. Vol. 14, I.4. P.11-113.
  63. Singhal R.L., Corman L.C. Subacute herpes simplex virus type 1 encephalitis as an initial presentation of chronic lymphocytic leukemia and multiple sclerosis: a case report // J. Med. Case Reports. 2011. Vol. 5. P. 59.
  64. Stagg M.P., Gumbart C.H. Chronic lymphocytic leukemic meningitis as a cause of the syndrome of inappropriate secretion of antidiuretic hormone // Cancer. 1987. Vol. 60. P. 191-192.
  65. Stübgen J.P. Lymphoma-associated dysimmune polyneuropathies // J. Neurol. Sci. 2015. Vol. 355(1-2). P. 25-36.
  66. Swerdlow S.H et al. WHO classification of tumours of haematopoietic and lymphoid tissues: International Agency for Research on Cancer. Lyon, 2008.
  67. Travis L.B., Curtis R.E., Hankey B.F. et al. Second cancers in patients with chronic lymphocytic leukemia // J. Natl. Cancer Inst. 1992. Vol. 84. P. 1422-1427.

© Терегулова Д.Р., Бакиров Б.А., Байков Д.Э., Ахмадеева Л.Р., 2015

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах